Confluent (CFLT) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.29%. A quarter ago, it was expected that this data infrastructure software maker would post earnings of $0.05 per share when it actually produced earnings of $0.09, delivering a surprise of 80%.Over the last four quar ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40526 CONFLUENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 47-1824387 (State or othe ...

Confluent (CFLT) Q1 2025 Earnings Call April 30, 2025 04:30 PM ET Speaker0 Welcome to the Confluent Q1 twenty twenty five earnings conference call. I'm Sheng Zhee from Investor Relations, and I'm joined by Jay Krebs, Co Founder and CEO and Rohan Siviram, CFO. During today's call, management will make forward looking statements regarding our business, operations, market and product positioning, growth strategies, financial performance and future prospects, including statements regarding our financial guidanc ...

Investor Presentation This presentation also contains statistical data, estimates and forecasts made by independent parties and by us relating to market size and growth, as well as other data about our industry and business. These data involve a number of assumptions and limitations, and we have not independently verified the accuracy or completeness of these data. Neither we nor any other person makes any representation as to the accuracy or completeness of such data or undertakes any obligation to update ...

Exhibit 99.1 Confluent Announces First Quarter 2025 Financial Results MOUNTAIN VIEW, Calif. -- April 30, 2025 -- Confluent, Inc. (NASDAQ: CFLT), the data streaming pioneer, today announced financial results for its first quarter of 2025, ended March 31, 2025. "Confluent started the year with solid momentum, achieving subscription revenue growth of 26% year over year," said Jay Kreps, co-founder and CEO, Confluent. "Our growth at scale amid heightened macroeconomic uncertainty demonstrates the mission-critic ...

Group 1 - Moretus Investments L.P. is a value-focused hedge fund that specializes in identifying deeply undervalued businesses trading significantly below intrinsic value [1] - The firm has a disciplined, fundamentals-driven approach that has produced exceptional returns, exemplified by an early recommendation of Carvana at $5, which generated a 50x return for investors within two years [1] - The Chief Investment Officer's early career experiences at Saxo Bank and Bloomberg have shaped the investment philosophy and approach at Moretus [1] Group 2 - The goal of the Chief Investment Officer on Seeking Alpha is to share practical, actionable insights drawn from experience as a hedge fund manager [1] - The content is aimed at long-term investors seeking compelling value opportunities amidst daily market fluctuations, providing rigorous analysis and clear perspectives [1]

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Confluent (CFLT) . This company, which is in the Zacks Internet - Software industry, shows potential for another earnings beat.This data infrastructure software maker has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past ...

Core Viewpoint - Confluent (CFLT) has been upgraded to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Movement - The correlation between changes in a company's future earnings potential and its stock price movements is strong, largely due to institutional investors who adjust their valuations based on earnings estimates [3]. - An increase in earnings estimates typically leads to higher fair value for a stock, prompting institutional investors to buy or sell, which in turn affects stock prices [3]. Implications of the Upgrade - The rising earnings estimates and the Zacks rating upgrade for Confluent suggest an improvement in the company's underlying business, which could lead to an increase in stock price as investors respond positively [4]. - The Zacks Rank system effectively utilizes earnings estimate revisions to guide investment decisions, indicating that tracking these revisions can be beneficial [5]. Zacks Rank System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [6]. - The system maintains a balanced distribution of 'buy' and 'sell' ratings across over 4000 stocks, ensuring that only the top 20% receive a 'Strong Buy' or 'Buy' rating [8][9]. Earnings Estimate Revisions for Confluent - For the fiscal year ending December 2025, Confluent is expected to earn $0.35 per share, reflecting a 20.7% increase from the previous year [7]. - Over the past three months, the Zacks Consensus Estimate for Confluent has risen by 2.6%, indicating positive sentiment among analysts [7].

Core Insights - Confluent Medical Technologies has launched Ultra Polyimide, the strongest polyimide tubing in the industry, offering nearly double the strength of traditional polyimide [1][2] - The new material allows for thinner walls in medical devices without compromising strength, addressing the evolving needs of device engineers [2] - Ultra Polyimide is manufactured without harmful solvents, ensuring regulatory compliance and enhancing safety for both workers and patients [3] Company Overview - Confluent specializes in the design, development, and large-scale manufacturing of interventional catheter-based devices and implants, with expertise in materials like Nitinol and high-precision polymer tubing [4] - The company operates multiple facilities across the United States and internationally, establishing a strong reputation in the medical device community [4]

Data streaming specialist Confluent's (CFLT -12.19%) stock was streaming in the wrong direction these past few trading sessions. A fairly aggressive price target cut from an analyst was a catalyst for this, and the share price was down by almost 13% week to date as of early Friday morning, according to data compiled by S&P Global Market Intelligence.A big chop from a bullThe downgrading party was Truist Securities analyst W. Miller Jump. As part of a broader analysis of the infrastructure and security softw ...